Welcome to our dedicated page for Ainos SEC filings (Ticker: AIMD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Ainos, Inc. filings document operating results, material agreements, governance matters, and the securities structure of a Nasdaq-listed company with AIMD common stock and AIMDW warrants. Form 8-K reports cover annual and quarterly financial results, AI Nose commercialization updates, distribution rights for AINOS AI Nose products and services, and amendments to product-development and patent-use arrangements.
The company’s proxy materials disclose director elections, shareholder voting matters, compensation information, and governance procedures. Its filings also describe relationships involving Taiwan Carbon Nano Technology Corporation and Ainos KY, including control and voting-power matters relevant to the company’s corporate governance and development agreements.
Ainos, Inc. (AIMD) filed its Q3 2025 10‑Q, reporting continued operating losses with limited cash. Nine‑month revenue was $113,037, up from $20,729, driven mainly by VOC sensing co‑development and modest VELDONA Pet sales. Net loss was $10,302,714, and operating loss reached $9,692,751. Cash and cash equivalents were $1,128,217 at September 30, 2025. The company disclosed “substantial doubt” about its ability to continue as a going concern.
To support liquidity, Ainos used its at‑the‑market program with H.C. Wainwright, selling 674,867 shares for $1,852,895 in net proceeds through September 30 and an additional 18,837 shares for $68,151 from October 1 to November 13. Shares outstanding were 4,793,797 as of September 30 and 4,812,634 as of November 13, 2025, following a 1‑for‑5 reverse split effective June 30. R&D expenses were $5,626,514 and SG&A $4,159,627 for the first nine months, reflecting ongoing investment in AI Nose, POCT, and VELDONA development while the business advances pilot deployments and partnerships.
Ainos, Inc. (AIMD) filed an 8-K detailing shareholder voting results and the furnishing of a press release with results for the quarter ended September 30, 2025.
At the November 7 Annual Meeting, a quorum was present with 3,226,793 votes, representing approximately 67.63% of outstanding votes. Seven directors were elected with vote support near or above 98%. Shareholders approved the ratification of YCM CPA INC. as independent auditor for the fiscal year ending December 31, 2025.
Shareholders also approved the reservation of up to 950,000 shares of common stock as special stock awards not issued under the 2023 Stock Incentive Plan. As of the September 17 record date, 4,771,184 common shares were outstanding and entitled to vote. The company furnished, but did not file, a press release announcing quarterly results as Exhibit 99.1.
Ainos, Inc. entered a Fourth Addendum to its Product Development Agreement with Taiwan Carbon Nano Technology Corporation (TCNT). The amendment sets a fee for the exclusive use of patents of $50,000 per month plus 5% sales tax for a two-year period starting October 16, 2025, replacing the prior one-year period starting October 16, 2024.
TCNT controls the company through its majority interest in Ainos KY and direct ownership, with Ainos KY holding majority voting power via voting agreements. The parties may negotiate payment terms and subsequent licensing methods after the two-year period. An English translation of the Fourth Addendum is filed as Exhibit 10.1.
Taiwan Carbon Nano Technology Corporation (TCNT) reports it directly holds 1,037,206 shares of Ainos, Inc. common stock, representing 21.79% of the outstanding shares after the issuer's one-for-five reverse stock split. TCNT acquired a larger position when the issuer issued 5,500,000 shares under a license agreement in exchange for patent rights and subsequently adjusted for the reverse split.
TCNT sold 62,794 shares between the end of June and early October and states those sales were for general operating purposes. TCNT is subject to a voting agreement that requires it to vote its shares as directed by Ainos KY while Ainos KY holds at least 10% of the issuer's shares. No litigation or other arrangements are disclosed.
Ainos Inc. amended its Schedule 13D to report ownership and recent transactions involving the issuer's common stock. After a June 30, 2025 one-for-five reverse stock split, Ainos KY directly holds 491,263 shares, representing 9.13% of the expanded share count basis. The filing discloses additional voting relationships: 933,958 shares under a January 26, 2024 voting agreement with the Tsai Group, 100,500 shares under a March 7, 2024 voting agreement, 635,652 shares tied to ASE Test via a May 3, 2024 agreement (including convertible notes and warrants), 1,037,206 shares under an August 15, 2024 agreement with TCNT, and 55,275 shares under a March 10, 2025 agreement.
The filing states the direct holdings of 491,263 shares were acquired for investment purposes, while TCNT sold 62,794 shares between June 25, 2025 and October 6, 2025 for general operating purposes. No other material contracts beyond the disclosed voting agreements are reported.
Form 4 disclosure: Taiwan Carbon Nano Technology Corporation, reported by Chun-Hsien Tsai as reporting person, recorded an insider sale in Ainos, Inc. (AIMD). On 10/06/2025 the reporting person sold 7,000 shares of common stock at a price of $3.59 per share for general operating purposes. Following the sale the reporting person beneficially owned 1,037,206 shares. The filer indicated the reporting relationship as Director and 10% owner. The Form 4 shows a routine, disclosed insider sale and provides the required Section 16 reporting details.
Ainos, Inc. (AIMD) reported a Form 4 showing that Taiwan Carbon Nano Technology Corporation, a director-related reporting person, sold 2,000 shares of common stock on 10/02/2025 at a price of $3.585 per share. After the sale the reporting person beneficially owned 1,044,206 shares. The filing states the shares were sold for general operating purposes. The Form 4 was signed on 10/06/2025 by the reporting entity's chairman and CEO.
Taiwan Carbon Nano Technology Corporation, identified as a director of Ainos, Inc. (AIMD), reported two open-market stock sales. On 09/30/2025 the reporting person sold 1,006 shares at $3.5167 each, reducing beneficial holdings to 1,047,906 shares. On 10/01/2025 they sold 1,700 shares at $3.4633, reducing holdings to 1,046,206 shares. The filing states the shares were sold for general operating purposes. The transactions are reported as direct beneficial ownership and coded as sales.
Ainos, Inc. provides details in its definitive proxy about ownership, director compensation and executive pay adjustments. Two large shareholders are disclosed: Taiwan Carbon Nano Technology Corporation holds 5,500,000 shares (35.64%) and ASE Test, Inc. holds 2,312,077 shares (13.05%). The document discloses board compensation rates including an annual chair retainer of $14,000, audit chair $7,000, compensation chair $4,500, audit committee members $4,000, and compensation committee members $3,000. Director ages are listed (examples: Wen-Han Chang 62; Yao-Chung Chiang 73; Pao-Sheng Wei 67). Chun-Hsien Tsai served as CEO and received a 2023 base salary of $122,517, bonus $115,313 and stock awards valued at $63,692. The proxy includes adjustments used to calculate "compensation actually paid" and reports total compensation actually paid figures (examples: $209,991, $440,794, $223,625, $551,615). The board will solicit proxies to ratify YCM as the independent registered public accounting firm for fiscal 2024 and to authorize adjournment of the annual meeting.